Special DNA-protein complexes, referred to as telomeres, are present at the ends of linear chromosomes. Telomeres protect chromosomal ends from degradation as well as prevent their fusion or illegitimate recombination with other chromosomes (for a review, see reference 12). In vertebrates, telomeric DNA is composed of multiple repeats of a short sequence (5Ј-TTAGGG-3Ј). Telomeric DNA, ranging from 10 to Ͼ50 kb in length, is complexed with multiple proteins which control the stability of telomeres. Telomeric DNA is synthesized by a multisubunit enzymatic complex, telomerase, consisting of the telomerase reverse transcriptase (TERT), an RNA component (TR) which acts as a template, and other associated proteins. Telomerase adds repeated sequences to the ends of linear chromosomes during cell division to overcome the "end replication problem" of linear DNA molecules. Recently, additional functions in cellular proliferation, survival, and carcinogenesis have been ascribed to telomerase (31, 54, 55) . Telomerase activity protects cells from apoptosis induced by serum deprivation or agents which induce doublestranded DNA breaks, such as hydroxyl radicals (4, 68, 95). The expression of TERT also enhances genomic stability and DNA repair (70). Finally, the overexpression of TERT leads to transcriptional alterations in the expression of a subset of genes, some of which enhance cell proliferation (38, 70, 74) .
Special DNA-protein complexes, referred to as telomeres, are present at the ends of linear chromosomes. Telomeres protect chromosomal ends from degradation as well as prevent their fusion or illegitimate recombination with other chromosomes (for a review, see reference 12). In vertebrates, telomeric DNA is composed of multiple repeats of a short sequence (5Ј-TTAGGG-3Ј). Telomeric DNA, ranging from 10 to Ͼ50 kb in length, is complexed with multiple proteins which control the stability of telomeres. Telomeric DNA is synthesized by a multisubunit enzymatic complex, telomerase, consisting of the telomerase reverse transcriptase (TERT), an RNA component (TR) which acts as a template, and other associated proteins. Telomerase adds repeated sequences to the ends of linear chromosomes during cell division to overcome the "end replication problem" of linear DNA molecules. Recently, additional functions in cellular proliferation, survival, and carcinogenesis have been ascribed to telomerase (31, 54, 55) . Telomerase activity protects cells from apoptosis induced by serum deprivation or agents which induce doublestranded DNA breaks, such as hydroxyl radicals (4, 68, 95) . The expression of TERT also enhances genomic stability and DNA repair (70) . Finally, the overexpression of TERT leads to transcriptional alterations in the expression of a subset of genes, some of which enhance cell proliferation (38, 70, 74) .
The activity of telomerase is high in germinal cells, contributing to their immortality, but is low in most somatic cells of homoeothermic vertebrates (28) . As a result, these somatic cells can divide for only a limited number of times before undergoing senescence or apoptosis. This reduction in telomerase activity reduces the risk of unrestricted somatic cell proliferation and malignant tumor growth. Telomerase, however, may be reactivated during tissue repair or the immune response (28, 86) . Telomerase also becomes reactivated in 90% of human tumors, and telomerase activity increases with tumor progression (34, 47, 79) . Telomerase is often reactivated in tumor cells by the abrogation of its original repression in somatic cells. The shortening of telomeres during proliferation of tumor cells leads to genomic instability, resulting in aberrations, such as partial chromosomal deletions and amplifications (71) . Chromosomal deletions often result in telomerase reactivation by removing loci encoding telomerase repressors (24) . The transcriptional repressor Mad1/c-Myc, the transforming growth factor beta pathway, and the tumor suppressor Menin are involved in telomerase repression (51) . In contrast, only a few oncogenes, including v-Myc, Bmi-1, E6 and E7 of human papilloma viruses (HPV 16 and HPV 18) , and the Bcl-2 proto-oncogene, directly upregulate telomerase activity without a requirement of genomic instability induced by telomere shortening (23, 44, 53, 84) .
The activity of telomerase in normal and neoplastic cells is regulated at several different levels (20) . Most of the known regulatory mechanisms operate by controlling the transcription or posttranslational modifications of the TERT subunit. Several transcription factors have been shown to regulate the TERT promoter, including c-Myc, Sp1, Sp3, and the estrogen receptor (56, 62, 84) . The activity of the human telomerase complexes also appears to be regulated by alternative splicing (33, 40) . Several variants of TERT are generated by splicing within the reverse transcriptase region and the C-terminal part of the TERT gene. The most frequently described spliced forms (␣ and ␤) lack telomerase activity, and the ␣-splice variant may function as an endogenous dominant-negative regulator of telomerase activity (19, 90) . The phosphorylation of TERT by Akt has been shown to play a regulatory role at the posttranslational level (37) . There are suggestions that Rel/ NF-B transcription factors may also play a role in the regulation of TERT. Rel/NF-B binding sites are present in the mouse TERT promoter, and a synthetic inhibitor of the IB kinase abrogates the constitutive and cytokine-induced upregulation of telomerase activity (2, 91) . The Rel/NF-B family member p65 (RelA) induces nuclear translocation of human TERT after both p65 and TERT become phosphorylated following the exposure of cells to tumor necrosis factor alpha (TNF-␣) (3) . However, a role for telomerase activation by Rel/NF-B family members in cell transformation has not been established.
v-Rel, a member of the Rel/NF-B family of transcription factors, is the oncogene expressed by avian reticuloendotheliosis virus (REV-T) (75, 88) . REV-T rapidly induces a fatal lymphoma in chickens and efficiently immortalizes splenic lymphocytes in vitro (49) . Moreover, REV-T transforms primary chicken fibroblasts and induces sarcomas in experimentally infected chickens (30, 57) . Because of the rapidity and efficiency with which v-Rel transforms cells and induces a fatal neoplastic disease, the v-Rel system provides a unique model for studying the role of Rel/ NF-B family members in carcinogenesis.
The altered expression of hundreds of genes contributes to tumor development; however, only a few genes are known to directly activate telomerase (23, 44, 53, 84) . In this report we demonstrate that v-Rel, in contrast to most other oncogenes, participates in the activation of telomerase. v-Rel employs several mechanisms to increase the levels of telomerase activity in transformed cells. The expression of TERT mRNA is directly elevated in cells expressing v-Rel. Additionally, v-Rel expression alters the ratio of alternatively spliced and fulllength TERT mRNA in favor of full-length forms which would encode functional telomerase proteins. Finally, v-Rel expression during transformation of splenic lymphocytes results in suppression of telomerase inhibitors. Telomerase activity in v-Rel-transformed cells is necessary for the protection of vRel-transformed lymphoid cells against apoptosis likely induced by increased levels of free oxygen radicals present in v-Rel-expressing cells.
MATERIALS AND METHODS
Cloning of avian TERT and TR. The chicken TERT gene was cloned from RNA obtained from a 5-day-old chicken embryos and inserted into the vector pTZ-18R, creating pTZ-TERT. A portion of the TR gene was reverse transcription-PCR (RT-PCR) amplified from chicken fibroblast genomic DNA using the GC-melt cDNA Advantage kit (BD Clontech Biosciences, Mountain View, CA) and primers TRP1 and TRP3 (Table 1) , which were designed based on the available chicken TR sequence (18) . This fragment was cloned into the vector pGEM-T Easy, creating pGEM-TR.
Retroviral expression vectors.
Two retroviral expression systems were used: one based on REV-T and the other on Rous sarcoma virus (RSV). The REV-Tbased plasmid pREV-TW, which encodes v-Rel, has been described previously (36, 60) . pREV-Tts-1 was created by a G-373E mutation of v-Rel using the v-G37E construct described by White et al. (87) . The chicken TERT gene was first modified by adding a Kozak sequence and XhoI cloning site before the start codon and an MluI cloning site 15 nucleotides (nt) downstream of the STOP codon. pREV-TERT was then created by cloning the XhoI-MluI TERT fragment into a REV-based retroviral construct, pREV-0 (36). pCSV11S3 contains an infectious genomic clone of chicken syncytial virus (CSV) (27) . The virus stocks of REV-T, REV-Tts-1, and REV-TERT were generated by cotransfection of pCSV11S3 with the respective plasmids pREV-TW, pREV-Tts-1, and pREV-TERT. CSV viruses were generated by transfection of the pCSV11S3 plasmid alone.
The plasmids pDS3 and pREP-A together encode an RSV-based replicationcompetent retroviral vector derived from a genomic clone of the Schmidt-Ruppin strain of Rous sarcoma virus (subgroup A) (22, 61) . The pDS3 plasmid was further modified to obtain pTZDS-XB by cloning a 2.1-kb SalI-SacI fragment of pDS3 into a polylinker in pTZ-18R (Amersham Biosciences Corp., Piscataway, NJ) and inserting an XhoI-NotI-SpeI-HpaI-BglII-BssHII adaptor into an unique BglII site. Coding sequences for v-Rel and v-Myc were cloned into pTZDS-XB to generate pTZDS-vRel and pTZDS-vMyc. The v-Rel coding sequence was derived from a previously described plasmid, pv-rel2 (36, 60) . pTZDS-vMyc was derived from a MC29 v-myc-encoding plasmid provided by Thomas Gilmore, Boston University, MA (6, 85) . DS(A), DS-vRel(A), and DS-vMyc(A) viruses were generated by transfection of concatemers of the respective pTZDS constructs ligated with pREP-A as described previously (35) .
Chickens and tissue culture procedures. Embryonated eggs from pathogenfree White Leghorn chickens were obtained from Charles River SPAFAS, North Franklin, CT. Chicken splenic lymphocytes were purified from 3-week-old chickens using Histopaque-1077 (Sigma, St. Louis, MO). Chicken embryonic fibroblasts (CEF) were prepared from 10-day-old embryos. Cells were cultured with Dulbecco's modified Eagle's medium supplemented with 5% fetal calf serum (Atlanta Biologicals, Norcross, GA), 5% chicken serum (Invitrogen, Carlsbad, CA), 100 U of penicillin, and 50 g of streptomycin per ml. Secondary cultures of CEF were used for transfection of plasmid DNA by a calcium-phosphate method as described previously (35) . Viruses were harvested between 5 and 7 days after transfection and infectious titers of Rel-expressing viruses determined by an immunochemical titration assay (36, 76) .
Cell lines. 123/12, 160/8, 160/2, 123/6, 123/6T, and 123/8 are v-rel tumorderived cell lines. 123/12 is a B-cell line, 160/8 and 160/2 are T-cell lines, and 123/6, 123/6T, and 123/8 are non-B/non-T-lymphoid cell lines which express several myeloid markers (36) . DT40 and DT95 are B-cell lines established from avian leukosis virus-infected chickens bearing bursa-derived lymphoid tumors (7) . MSB1 and RP1 are T-cell lines established from Marek's disease virusinduced lymphomas (5, 59) . BM2 is a macrophage-like cell line derived by transformation of yolk-sac cells by avian myeloblastosis virus (58) . HD11 is a macrophage cell line derived from bone marrow cells infected by myelocytomatosis virus (10) . AEV1 is an avian erythroblastosis virus-transformed erythroid cell line (67) .
siRNA electroporation. Four chicken TERT-specific small interfering RNAs (siRNAs) were designed using guidelines proposed for the optimization of siRNAs (69, 94) . Preliminary experiments determined that two of these siRNAs decreased TERT mRNA levels. These double-stranded oligonucleotides, designated TE2 and TE4, have the following sequences: 5Ј-AUAAUCACUGCA  UACCACCUU-3Ј and 5Ј-GGUGGUAUGCAGUGAUUAUUU-3Ј, as well as  5Ј-CUGUCCAACCACAAAGUUAUU-3Ј and 5Ј-UAACUUUGUGGUUGG   TABLE 1. Oligonucleotide primers used for RT-PCR analyses   Name  Gene product  Sequence   SB1  TERT  5Ј-GATGGTTCCGTCACCGTCTTCAGCAGTTC-3Ј  T4  TERT  5Ј-CCAGATTGTCGCTTGATCTCATGGTGTG-3Ј  KbSpA  TERT  5Ј-CAGCCTTCTGCAAAAGTGAACTTTCAAGCAGGTAATC -3Ј  KbSpWT  TERT  5Ј-AGTGAATGACTGCGTATGGCTTCGTCTGG-3Ј  T6  TERT  5Ј-CCACACCATGAGATCAAGCGACAATCTGG-3Ј  TRP1  TR  5Ј-AGGCTCCGCTGTGCCTAACCCTAATCG-3Ј  TRP3  TR  5Ј-GCGCCGCTCCCGTTTGCTCTGCTG-3Ј  GAPDH1  GAPDH  5Ј-TCATCTGAAGGGTGGTGCTAAGCGTG-3Ј  GAPDH2  GAPDH  5Ј-TCTGGGCAGCACCTCTGTCATCTCTC-3Ј 282 HRDLIČ KOVÁ ET AL. J. VIROL.
ACAGUU-3Ј, and target the regions of TERT mRNA located 2,865 and 3,881 nucleotides downstream of the start codon. These siRNAs and a negative control, 1NC (negative control #1; Ambion, Austin, TX) were synthesized using the siRNA construction kit (Ambion). Additionally, we employed an siRNA chemically synthesized by Ambion that targets chicken TR (TR1 [5Ј-GCUGUGCCU  AACCCUAAUCUU-3Ј and 5Ј-GAUUAGGGUUAGGCACAGCGG-3Ј] ). This siRNA binds to the region of TR that is used as the template for the synthesis of telomeres (26) . siRNAs (6 g) were electroporated into exponentially growing cells (10 5 ) using siPORT siRNA electroporation buffer (Ambion) at 1 F and 0.4 kV. After electroporation, cells were placed into regular medium, and the levels of TERT mRNA and the extent of apoptosis were analyzed 24 h later. RNA was isolated using an RNAqueous-Micro kit (Ambion), and TERT mRNA was measured by RT-PCR as described below.
Determination of cell resistance to oxidative challenge. Exponentially growing HD11 cells expressing TERT or helper virus (0.5 ϫ 10 6 ) were washed, resuspended in 1 ml of culture media, and seeded in 12-well plates. Freshly diluted t-butyl hydroperoxide (t-BHP) (Sigma) was added for 24 h, and the extent of apoptosis in these cells was determined by measuring DNA content in ethanolfixed cells by propidium iodide staining and flow cytometry.
Determination of apoptosis by flow cytometry. Cells were washed and resuspended in 300 l 5 mM EDTA in phosphate-buffered saline (PBS) (PBS-EDTA). Then, 700 l of 100% ice-cold ethanol was added and cells were stored at 4°C before analysis. Cells were pelleted and resuspended in 500 l of PBS-EDTA, and RNA was digested by incubation with 50 l of RNase A (10 mg/ml) for 30 min at room temperature. Then, 500 l of propidium iodide solution (100 g/ml in PBS) was added, and dye incorporation was determined with a FACSCalibur flow cytometer (BD Immunocytometry Systems, San Jose, CA). The fluorescence emitted by cell aggregates was excluded based on the theory of doublet discrimination as described by the manufacturer (FACSCalibur system user's guide; BD Immunocytometry Systems; 1996). The percentage of cells with a DNA content lower than that of the G 1 phase was calculated using the CellQuest software provided with the FACSCalibur instrument.
Determination of reactive oxygen species content. 2Ј,7Ј-dichlorodihydrofluorescein diacetate (H 2 DCFDA) (Sigma) was dissolved at a 20 mM concentration in absolute ethanol and stored at Ϫ70°C. Culture medium was replaced with medium containing 5 ⌴ concentration of H 2 DCFDA, and cells were incubated under CO 2 at 37°C for 30 min. Cells then were harvested, washed, and resuspended in PBS with 2% chicken serum. Fluorescence was determined by flow cytometry using a FACSCalibur instrument.
TRAP. The level of telomerase activity was evaluated using the telomerase repeat amplification protocol (TRAP) assay. Whole-cell extracts were prepared with CHAPS buffer (42) . Cells (1 ϫ 10 7 to 2 ϫ 10 7 ) were extracted with 200 l of CHAPS buffer on ice for 30 min and centrifuged at 10,000 ϫ g at 4°C for 5 min, and supernatant fluids were stored at Ϫ70°C. Extracts from cytoplasmic and nuclear fractions were prepared using a nuclear extract kit (Active Motif, Carlsbad, CA) with 2 mM phenylmethylsulfonyl fluoride added to the hypotonic buffer. Protein concentrations were determined by the Bradford method with protein assay reagent (Bio-Rad Laboratories, Hercules, CA).
Two different TRAP assays were performed. For lymphoid cells, with high telomerase activity, single-tube extension PCR TRAP assays were used, while for fibroblasts and HD11 cells, which generally have low telomerase activity, the two-tube extension PCR protocol was employed. In the single-tube extension PCR TRAP assay, the protein extracts (100 ng of total protein or less) were incubated with primers, control template, deoxynucleoside triphosphates (dNTPs), polymerase, and 1ϫ TRAP reaction buffer as described by Kim and Wu (43) except that 0.1 g unlabeled TS primer and 2 U Platinum Taq polymerase (Invitrogen) were used. Incubation for 30 min at 30°C was followed by a 2-min incubation at 94°C and by PCR amplification with 33 cycles (30 s at 94°C, 30 s at 50°C, 1 min at 72°C). In the two-tube extension PCR TRAP assay, protein extracts (20 g of total protein or less) were first incubated with 0.5 g of the TS primer and all four dNTPs (1 mM each) in 1ϫ TRAP reaction buffer, 0.8 mM spermidine, 5 mM ␤-mercaptoethanol in a total reaction volume of 50 l for 30 min at 37°C. The reaction was stopped by incubation at 94°C for 2 min. Aliquots of synthesis (2.5 l) were then PCR amplified as described by Kim and Wu (43) except that 0.1 g unlabeled TS primer and 1 l Advantage cDNA polymerase mixture (BD Biosciences Clontech) were employed. PCR amplification started with 94°C for 2 min followed with 33 to 35 cycles (30 s at 94°C, 30 s at 50°C, 1 min at 72°C). The TRAP PCR products were then separated on 7.5% polyacrylamide gels (ratio of acrylamide to bisacrylamide, 19:1) in 0.5ϫ TBE (TBE is 0.09 M Trisborate, 2 mM EDTA, pH 8.0). Gels were stained with VISTRA Green (Amersham Biosciences) diluted 1:4,000 in 0.5ϫ TBE for 1 h, and images were captured using a Fluorimager (Amersham Biosciences). For molecular weight determination, a 10-bp ladder was used (Invitrogen).
Terminal restriction fragment (TRF) length analysis. High-molecular-weight genomic DNA was digested with a cocktail of restriction enzymes (HinfI, HaeIII, MspI, and RsaI). DNA samples (0.2 g) were then separated in 1ϫ TBE in a 0.7% agarose gel. Undigested phage DNA mixed with digested with EcoRI and HindIII was used as a marker. DNA was transferred by using a standard Southern blot technique to a Hybond-Nϩ membrane (Amersham Biosciences) and hybridized to the telomeric probe (CCCTAA) 6 end-labeled with [␥- 32 P]ATP at 42°C using the Ultrahyb solution (Ambion). Blots were washed as suggested by the Ultrahyb manufacturer. The blots were autoradiographed at Ϫ70°C using intensifying screens. Subsequently, the blots were rehybridized with a probe to visualize the position of the marker.
Western analysis. Western analysis was performed as described previously (36) . Briefly, harvested cells were washed, resuspended, boiled in sodium dodecyl sulfate sample buffer, and the total protein concentration in the lysate was determined by the Bradford method with a Bio-Rad protein assay reagent (BioRad Laboratories). Volumes of lysate lower than 1 l were used in the total reaction volume of 1 ml to avoid interference of the Bradford assay reagent with chemicals in the lysates. Proteins were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred to a PolyScreen polyvinylidene difluoride membrane (PerkinElmer Life Sciences, Boston, MA). Monoclonal antibody HY87 was used to detect the expression of v-Rel and avian c-Rel (36) .
Northern analysis and probes. Total RNA was isolated by RNAwiz (Ambion). RNA was separated by electrophoresis in a 1% agarose gel in 20 mM MOPS Boundaries of some of the fragments used fall outside of the published sequence because these GenBank sequences are incomplete. The GenBank nucleotide sequence referred to is the sequence of the molecular clone used to prepare the probe fragments, with the exception of Rac1, GAPDH, and the env probes. The Rac1 and GAPDH probes were RT-PCR amplified from chicken RNA. The env gene fragment was obtained using a subclone of pCSV11S3. The clones pgl1n.pk011.l10, encoding chicken Nox2, pgf1n.pk006.p7, encoding chicken Rac2, pgf1n.pk006.k23, encoding chicken MnSOD, and pgl1n.pk007.i17, encoding chicken catalase, were purchased from the University of Delaware. Identification of TERT and its alternatively spliced variants by semiquantitative reverse transcription-PCR. Total RNA was isolated by RNAwiz (Ambion). The samples of RNA used for detection of wild-type and alternatively spliced variants of TERT and avian GAPDH by RT-PCR were first pretreated with DNase I ("DNA-free" reagent; Ambion) to remove traces of DNA in the RNA preparations. Total RNA (1 g) together with 1 l of 10 M LDP primer were denatured for 10 min at 70°C in 11 l of water (35) . First-strand cDNA synthesis was carried out with 15 U of ThermoScript reverse transcriptase (Invitrogen), 2 l of 10 M dNTP, and 2 l of 100 M dithiothreitol at 50°C for 1 h. The reaction was stopped by a 5-min incubation at 85°C. The RNA was destroyed by RNase H treatment, and the reaction was diluted with 100 l of water. For detection of avian TERT, its alternative spliced variants, and GAPDH by RT-PCR, 2 l of the first-strand synthesis reaction was used together with 1 l Advantage cDNA polymerase mix (BD Clontech Biosciences) and with primers, which include T4 and SB1 primers for avian TERT; KbSpWT or KbSpA and T6 primers for the alternatively spliced variants of TERT; and GAPDH1 and GAPDH2 primers for the GAPDH gene (77) ( Table 1 ). KbSpWT and T6 primers detect only TERT without alternative splicing A, because the KbSpWT primer is located in the region which is deleted by this splicing event. The KbSpA and T6 primers detect only TERT with alternative splicing A, because the KbSpA primer anneals at the junction created by alternative splicing A and is not able to prime the synthesis of wild-type TERT. PCRs were performed as follows: 5 cycles (30 s at 94°C and 3 min at 72°C), 5 cycles (30 s at 94°C, 30 s at 70°C, and 3 min at 72°C), and 25 to 50 cycles (30 s at 94°C, 30 s at 65°C, and 3 min at 72°C). The PCR for detection of chicken TR was performed in the same way with primers TRP1 and TRP3 for the TR gene (Table 1) were infected with REV-T at a multiplicity of 1. Extracts for the TRAP assays were harvested from cells before infection (day 0) and at various times after infection (lanes 1 to 12). In negative control assays, the samples were pretreated by heating at 85°C for 15 min before subjecting them to the TRAP assay (lanes 13 to 14). In an independent experiment, the telomerase activity detected by TRAP and v-Rel expression detected by cDNA polymerase mix with 10 l GC-melt was added instead of the regular Advantage cDNA polymerase mix to facilitate the amplification of GC-rich sequences (BD Biosciences Clontech). The annealing temperature was increased to 68°C.
Electrophoretic mobility shift assays. The assays were performed as described previously (45) . The TERT B1 probe was prepared by annealing oligonucleotides (5Ј-GTTTCATAGCTGAGAGTTTTCTCTATCAAA-3Ј and 5Ј-TTTGAT AGAGAAAACTCTCAGCTATGAAAC-3Ј), followed by end labeling with [␥-
32 P]ATP. The TERT B2 probe was prepared by annealing oligonucleotides (5Ј-TCCAACGATGGTGACTCCACGCCCTCCTTG-3Ј and 5Ј-CAAGGA GGG-3Ј), followed by a Klenow fill-in reaction using [␣-
32 P]dCTP as described previously (45) .
GenBank accession numbers. Newly determined nucleotide sequences were submitted to GenBank (AY626231 [chicken TERT], AY626232 [chicken TR], DQ148459 to DQ148473, and DQ177327 [alternatively spliced isoforms of chicken TERT]).
RESULTS
Telomeres of v-Rel-transformed cell lines are longer than telomeres of normal chicken cells. Cells transformed by the majority of oncogenes are able to escape mortality 1 (M1) crisis, a growth arrest triggered by the shortening of telomeres (72) . These cells, however, usually enter the second (M2) crisis phase when extremely short or absent telomeres are unable to protect chromosome ends. At this stage a few M2 cells may emerge in which telomerase (or the alternative lengthening of telomere mechanism) has been activated and telomere length stabilized. Consequently, telomeres in immortal transformed cells are generally shorter than telomeres in normal cells (48) . Lymphoid cells transformed by the v-rel oncogene do not enter a crisis phase prior to immortalization (36) . To determine how the absence of crisis affects telomeres in v-Rel-immortalized cells, telomere lengths in four v-Rel cell lines established from tumors were determined by TRF length analysis (Fig. 1A) . The average length of telomeres in v-Rel-immortalized cells was 50 kb or greater, while splenic lymphocytes from 2-week-old chickens or chicken embryonic fibroblasts had an average telomere length of 20 to 50 kb. The avian cell line MSB1, which is transformed by Marek's disease virus, also had longer telomeres than nontransformed chicken cells. Marek's disease virus, however, has acquired a functional copy of the avian TR gene, which is likely responsible for the long telomeres in cells transformed by this herpesvirus (29) . By contrast, the HD11 tumor cell line, which has low telomerase activity, had very short telomeres (some as short as 2 kb). Human DNA had significantly shorter telomeres (about 10 kb) than chicken cells. In summary, v-Rel transformation of hematopoietic cells results in the maintenance and extension of telomeres, which is consistent with the observation that v-Rel transforms these cells without undergoing crisis induced by extremely short telomeres.
v-Rel increases telomerase activity during transformation of splenic cells and fibroblasts. To determine whether the long telomeres in v-Rel-transformed cells correlate with telomerase activity in these cells, we examined the levels of telomerase in immortalized v-Rel-transformed cell lines. All lymphoid v-Rel cell lines examined showed significant levels of telomerase activity (Fig. 1B, lanes 1 to 6) . Differences in telomerase activity were not detected among the different phenotypic classes of v-Rel-transformed cells: B, T, or non-B/non-T. Telomerase activity in most of these cell lines was two to three times higher than the activity detected in splenic lymphocytes obtained from young chickens (lane 14). In contrast, telomerase activity in other transformed avian cell lines of hematopoietic origin varied greatly, from undetectable or low (HD11, MSB1; lanes 8 and 11) to very high activity (AEV1, RP1; lanes 7 and 10). These results indicate that v-Rel-immortalized cells maintain high telomerase activity.
Transformed immortal lymphoid cell lines can be readily established by the infection of splenic cells in vitro with the v-Rel-expressing retrovirus REV-T. To assess changes in telomerase activity during the in vitro transformation process, splenic lymphocytes were infected with REV-T. Telomerase activity in these cells was determined 2, 6, and 12 days after infection and compared to that of uninfected splenic cells harvested at the beginning of the experiment (Fig. 1C, lanes 1  to 12) . Since telomerase is a heat-sensitive enzyme, extracts were also heated to 85°C before the TRAP assay was performed to demonstrate that the PCR-amplified products were the result of TERT enzymatic activity (lanes 13 and 14). Initially the cultures contained a substantial proportion of v-Relnegative cells, because REV-T can replicate in only a small proportion of the splenic cells (36) . The majority of the cells undergo apoptosis in vitro, while v-Rel-expressing cells proliferate. By day 6, the majority of cells expressed v-Rel, displayed a transformed morphology, and exhibited a dramatic increase in telomerase activity. The telomerase activity in transformed cells exceeded the activity in the initial cell population 4-fold at day 6 (lanes 7 to 9) and more than 10-fold at day 12 (lanes 10 to 12). This increase in telomerase activity temporally correlated with the increased expression of v-Rel in the lymphocyte cell population (lanes 15 to 18). These results demonstrate that Western analysis were determined for the same samples (lanes 15 to 18). Telomerase activity was measured by a single-tube TRAP assay using aliquots of the extracts containing 200 ng (dilution 1), 40 ng (dilution 1/5), or 8 ng (dilution 1/25) of total protein (lanes 1 to 14) or 100 ng of total protein (lanes 15 to 18). (D) Telomerase activity in chicken embryonic fibroblasts transformed by v-Rel. Extracts for the TRAP assays were prepared from chicken embryonic cells used to establish the primary cultures (EC) prior to their adhesion to the tissue culture dish, from uninfected CEFs (UN), CEFs infected with the control DS(A) virus (VC), CEFs transformed by DS-vRel(A), and by DS-vMyc(A) (lanes 1 to 5, 9 to 20). Cells were infected by these retroviruses 1 week after the establishment of the primary cultures and passaged for another 7 days. Uninfected CEFs at the same passage number served as controls. Negative control assays with heat-treated extracts were also performed (lanes 6 to 8). (30, 57) . Therefore, the level of telomerase activity was evaluated in v-Rel-transformed CEF cultures (Fig. 1D) . CEF cultures (second passage) were infected with RSV subgroup A-based retroviruses expressing v-Rel or an empty vector control (VC) or left uninfected. CEF cultures were also infected with the same retroviral vector expressing v-Myc, a well established activator of telomerase (25) . Telomerase activity was determined 7 days after infection. Consistent with the previously published re- . Electrophoretic mobility shift assays were performed with 2.5 g of nuclear extracts and 32 P-labeled probes encompassing the B1 (left panel) and B2 (right panel) sites found in the TERT promoter. Supershift analysis was performed by preincubating the nuclear extract from v-Rel-expressing cells with normal rabbit serum (NRS) or antisera specific for v-Rel (␣v-Rel) prior to the addition of probe. Free probe (FP) and the binding reactions were resolved on a 5% nondenaturing polyacrylamide gel. The four bands that were supershifted by the addition of v-Rel-specific antisera are indicated. Asterisks indicate the locations of the supershifted v-Rel-containing complexes.
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sults, after a few serial passages in vitro, telomerase activity in fibroblasts becomes very low relative to the activity in the embryonic cells used to establish the primary cultures (Fig. 1D , lanes 1 and 2) (41, 78). Seven days after infection, a substantial increase in telomerase activity was detected in v-Rel-expressing cells and a similar increase was found in v-Myc-expressing fibroblasts (lanes 4 and 5). Only a slight increase in telomerase activity was observed in vector control-infected cells (lane 3). Further measurements (lanes 9 to 20) established that the level of telomerase activity in v-Rel-expressing cells was at least 10 times higher than that in vector control cells. By contrast, several avian oncogenes (with exception of v-Jun), including v-Src, activated c-Ha-ras, c-Ski, v-PI-3-kinase, and v-Ros, did not induced telomerase activity in the fibroblast cultures they morphologically transformed (R. Hrdličková, J. Nehyba, and H. R. Bose, unpublished results). These results indicate that v-Rel is able to reactivate telomerase activity in cells where this activity was previously suppressed. HD11 is an immortal macrophage cell line which expresses very low levels of telomerase activity. The infection of these cells with REV-T results in changes in their morphology accompanied by the overexpression of several v-Rel target genes activated in hematopoietic lineages (data not shown). We therefore evaluated whether the expression of v-Rel in these cells results in the induction of telomerase activity (Fig. 1E) . HD11 cells were infected with REV-T, and v-Rel expression and telomerase activity were analyzed 4 days after infection. HD11 cells expressed significant levels of v-Rel, and telomerase activity was increased more than 20 times. Collectively, these experiments suggest that the induction and maintenance of high telomerase activity may be an obligatory step in v-Rel tumorigenesis.
The expression of v-Rel directly increases the level of TERT.
The reverse transcriptase (TERT) and the RNA component of telomerase (TR) are two essential components of the telomerase enzymatic complex. Since v-Rel is a transcription factor, we evaluated whether the steady-state levels of TERT mRNA and TR RNA were altered in response to v-Rel expression ( Fig. 2A) . Total RNA was harvested from transformed splenocytes 12 days after infection with REV-T and from control cells before infection. RT-PCR analysis demonstrated that in v-Rel-transformed lymphocytes, the level of TERT mRNA was increased approximately 10-fold and TR expression more than 10-fold ( Fig. 2A) . These results suggest that the increased levels of TERT and TR RNA may contribute to the elevated activity of telomerase observed in v-Reltransformed cells.
To assess whether the increased levels of TERT were a direct effect of v-Rel expression, a temperature-sensitive (ts) transformation mutant of v-Rel (ts-1 v-Rel) was employed ( Fig. 2B) (87) . HD11 cells were infected with retroviruses expressing v-Rel or ts-1 v-Rel and incubated for 4 days at the permissive temperature (36.5°C), and the expression of v-Rel was confirmed by Western blot analysis. RNA from some of these cultures was harvested for analysis of TERT mRNA levels. Other cultures were transferred to the nonpermissive temperature (41.5°C) for 24 h, and RNA was harvested. At the nonpermissive temperature, the ts-1 v-Rel protein became inactivated and TERT mRNA was degraded (Fig. 2B) , whereas in cells expressing wild-type v-Rel, TERT mRNA continued to be synthesized. To determine if the change in TERT mRNA levels was a direct consequence of v-Rel activity, the remaining cultures were transferred to permissive temperature in the presence of the protein synthesis inhibitor cycloheximide (10 g/ml), and RNA was isolated after 3 h. After a shift to the permissive temperature, ts-1 v-Rel becomes active but other proteins are not synthesized due to the presence of the protein synthesis inhibitor. Therefore, any increase in the levels of TERT mRNA would be the result of the activation of ts-1 v-Rel. The ts-1 v-Rel mutant induced the expression of TERT in cells, while the levels of TERT mRNA remained the same in control cultures. The increase of TERT RNA levels is, therefore, a direct result of v-Rel activation.
To further investigate the role of v-Rel in the activation of TERT expression, we analyzed the promoter of chicken TERT (21) . Two potential B sites, at 189 and 535 bp upstream of the transcription start site, were identified. Electrophoretic mobility shift assays were performed to define whether v-Rel binds to either of these B sites. As shown in Fig. 2C , multiple complexes in nuclear extracts from v-Rel-transformed CEF cultures bound to both of these B sites. Four complexes were supershifted by antisera specific for v-Rel. Binding of v-Rel to these B sites further supports the notion that v-Rel directly upregulates the expression of the chicken TERT gene.
Changes in the splicing pattern of TERT result in higher abundance of full-length and in-frame-spliced forms in v-Reltransformed cells. Telomerase activity in human cells correlates with the presence of full-length TERT transcripts (80) . Seven alternatively spliced transcripts of the human TERT gene that encode proteins with internal deletions in the reverse transcriptase domain or truncations of the C terminus have been identified (33, 40) . The expression of these alternatively (19, 90) . Since these studies indicate that alternative splicing of TERT is an important mechanism in the regulation of human telomerase activity, we investigated whether TERT transcripts are also alternatively spliced in the chicken. Analysis of chicken splenic lymphocytes and v-Rel-transformed lymphoid cells revealed the presence of 16 alternatively spliced variants, which included forms with exon skipping, inclusion of a new exon cassette, intron retention, and the modification of exon boundaries as a result of employing an alternative splice donor or acceptor site ( Table 2) . Six of these splicing events introduced novel stop codons which would lead to prematurely terminated proteins during translation. In most of the remaining forms, these splicing alterations resulted in the removal or disruption of functional RNA interaction domain 2 or reverse transcriptase motifs. Subsequently, we analyzed the frequency and combinatorial pattern of these splicing events in naive splenic cells, concanavalin A (ConA)-stimulated splenic cells, splenic cells 12 days after transformation by v-Rel, and v-Rel-transformed cell lines of splenic origin in order to determine if differences in the telomerase activity in these cells correlate with the frequency of alternatively spliced forms (Table 3 ). The percentages of the isoforms with alternative splicing A and without A were established in separate measurements. The alternatively spliced forms were the most abundant. Thirty-six distinct combinations of one to six splicing events per molecule were detected. Fulllength wild-type (WT) forms were not detected in naive splenic cells, suggesting that they represented less than 10% of the TERT mRNA. Activation of splenic cells by ConA was accompanied by an activation of Rel/NF-B and resulted in a fivefold increase in telomerase activity (data not shown). Simultaneously, in these cells the amount of the WT TERT mRNA increased to 10% of that of the AϪ forms. The transformation of splenic cells with v-Rel led to more than a 10-fold increase in telomerase activity (Fig. 1C) , and the percentage of WT forms was elevated to 60% of the AϪ forms. In established v-Rel-transformed splenic cell lines (123/12, 160/2, and 123/ 6T), high percentages of WT TERT transcripts were also detected (10 to 50% of AϪ forms), albeit at a lower frequency than in recently transformed cells. The somewhat lower abundance of the WT TERT transcripts correlated with the level of telomerase activity, which was also lower in established cell (20) AD (10) ABD (60) 123/12 WT (23) BLE (8) 85:15 A (7) ABDG (14) 79:21 I (31) BLDGF (8) AB (36) ABLG (7) B (23) ABD (21) D (8) ABF (14) 160/2 WT (10) BG (10) 70:30 A (8) ABCDGN (8) 83:17 B (50) GI (10) AB (25) ABDGI (8) BD (10) BCF (10) AD (8) AF (8) AG2 (8) ABD (25) 123/6T WT (50) BDG (8) 92:8 A (27) AG (9) 91:9 B (42) AB (45) ABD (9) AI2F (9) a The regions of TERT gene spanning all the known alternative splicing sites were RT-PCR amplified and cloned and 10 to 15 clones from each sample sequenced. b Lymphocytes from spleens of 3-week-old chickens, freshly isolated, stimulated for 2 days with ConA (50 g/ml), or infected for 12 days with REV-T, as well as three v-Rel cell lines (123/12, 160/2, and 123/6T), were analyzed.
c The alternatively spliced variants with and without alternative splicing A were detected in two separate PCR amplifications utilizing the same 3Ј primer and two different 5Ј primers as described in Materials and Methods.
d TERT isoforms spliced in-frame. e TERT isoforms which encode prematurely terminated proteins. f Ratio of IF forms to PT forms. g WT, full-length wild-type forms.
lines than in cells undergoing transformation (Fig. 1) . The increase in the abundance of the WT TERT transcripts was also accompanied by a change in the ratio of forms which encode prematurely terminated proteins (PT) and forms spliced in-frame (IF). In uninfected spleen, PT forms were present in high frequency, while in recently transformed cells, only IF forms were detected. Collectively, these results suggest that the increased frequency of WT and other IF forms of TERT transcripts in v-Rel-transformed cells may represent an important regulatory mechanism which leads to the increased telomerase activity in these cells. Inactivation of inhibitors of telomerase activity in nuclei of v-Rel-expressing cells. The nuclear translocation of preexisting telomerase complexes during the activation of T cells by extracellular signaling has been proposed to lead to telomerase activation (52) . Additionally, RelA mediates the nuclear translocation of human TERT after exposure to TNF-␣ (3). To determine whether TERT nuclear translocation may contribute to telomerase activation by v-Rel, cytoplasmic and nuclear fractions obtained from splenic cells during transformation by v-Rel were analyzed for telomerase activity (Fig. 3) . Telomerase activity in whole-cell lysates and v-Rel expression were also determined (Fig. 1C, lanes 15 to 17) . Telomerase activity was detected in both cytoplasmic and nuclear extracts from cells prior to infection (day 0) and in cells 3 and 7 days after infection (Fig. 3) . In uninfected lymphocytes (day 0), nuclear telomerase activity in undiluted extracts (lane 5) was inhibited by an unknown mechanism. Dilution of this extract increased telomerase activity (lane 6), apparently by diluting out the inhibitory factor. In v-Rel-expressing cells (days 3 and 7), this inhibition was not detected. The ratio between telomerase activities in diluted nuclear and cytoplasmic extracts was approximately 1:1 during the entire experiment (with only a marginal increase in the nuclear-to-cytoplasmic ratio between days 3 and 7). However, as transformation by REV-T progressed, a substantial increase (fivefold) in telomerase activity was detected in both subcellular fractions. This analysis suggests that during v-Rel transformation, telomerase activity in the nuclei of lymphocytes is increased by the suppression of telomerase inhibitors present in uninfected cells.
Telomerase activity protects v-Rel-transformed cells against apoptosis. To determine whether telomerase expression is important for the maintenance of v-Rel-transformed lymphoid cells, telomerase activity in v-Rel-transformed cells was inhibited with 2,6-bis [3- (N-piperidino) propionamido]anthracene-9,10-dione (telomerase inhibitor V; Calbiochem, La Jolla, CA) and their survival evaluated ( Fig. 4; Table 4 ). Telomerase inhibitor V belongs to the new generation of telomerase inhibitors from the G-quadruplex DNA ligand family (64) . Telomeres contain a G-rich 3Ј overhang that can adopt an intramolecular G-quadruplex structure, which blocks the catalytic reaction of telomerase when stabilized by a G-quadruplex ligand. The exponentially growing v-Rel lymphoid cell lines 123/12, 160/2, 160/8, 123/6, and 123/6T were treated with a 5, 10, or 20 M concentration of the inhibitor dissolved in culture medium or left untreated. The avian macrophage-like cell line HD11 and the T-cell line MSB1, which both express undetectable or very low levels of telomerase activity, served as controls. Telomerase activity was determined at 24 h after treatment using the TRAP assay, and the extent of apoptosis was determined by measuring the DNA content of these cells by flow cytometry 48 h after treatment with the inhibitor ( Fig. 4A and B; Table 4 ). Telomerase activity was inhibited in cells exposed to the telomerase inhibitor, and an increased number of apoptotic cells was detected in v-Rel-transformed cell lines at a dose as low as 5 M. The proportion of apoptotic cells increased significantly with increasing concentrations of the telomerase inhibitor (Table 4) . At a concentration of 20 M, the inhibitor induced apoptosis in 37 to 85% of the v-Reltransformed cells. By contrast, the MSB1 and HD11 cell lines were not affected by exposure to even the highest concentrations of the inhibitor evaluated. DNA fragmentation analysis was performed to confirm that death of the v-Rel-transformed cells was due to apoptosis (data not shown).
Telomerase was also inhibited by decreasing TERT and TR RNA by siRNA technology (Fig. 4C and D) . Two siRNAs specific for chicken TERT sequences and one TR-specific siRNA were delivered alone or in combination into the 123/12 v-Rel-transformed cell line. The level of TERT mRNA was decreased up to 40% (Fig. 4C) . The level of TR decreased under the detection threshold. This inhibition correlated with the induction of apoptosis in these cells, while negative control siRNA had no effect on cell viability. The highest increase of apoptosis (120% above negative control) was reached by transfection of TE2 siRNA. These results suggest that telomerase activity in v-Rel lymphoid cell lines is necessary for maintenance of transformation by protecting these cells against apoptosis.
Expression of v-Rel increases sensitivity of cells to telomerase inhibition. In contrast to the HD11 and MSB1 cell lines, the v-Rel cell lines are extremely sensitive to inhibition of telomerase. There are two possibilities: either the target cells for v-Rel transformation are very sensitive to telomerase inhibition or v-Rel expression increases this sensitivity. To determine whether v-Rel expression is directly responsible for the high sensitivity to telomerase inhibition, HD11 cultures were infected by v-Rel-expressing retroviruses or control helper virus, and sensitivity to telomerase inhibitor V was determined Table 4 . (C) Decrease in expression of TERT and TR in the 123/12 v-Rel cell line after siRNA treatment. The 123/12 cell line was electroporated with TE2, TE4, and TR1 siRNAs (2 g each) or a control 1NC siRNA (6 g). RNA was harvested 24 h after electroporation, and the levels of TERT, TR, and GAPDH were analyzed by RT-PCR as described in the legend to ( Fig. 4E) . Five days after infection, HD11 cells expressed high levels of v-Rel and telomerase activity increased more than 20 times relative to that of cells expressing the helper virus alone (Fig. 1E) . The level of apoptosis in these v-Rel-expressing cells was higher (19.2%) than that in cells infected with the helper virus (1.7%) (Fig. 4E) . When v-Rel-expressing cells were exposed to a 20 M concentration of the telomerase inhibitor, the extent of apoptosis increased to 81.1% as determined by flow cytometry after 2 days of treatment. By contrast, the number of apoptotic cells in the control cultures showed only a slight increase (from 1.7% to 2.7%). These results demonstrate that v-Rel expression increases the sensitivity of cells to telomerase inhibition.
v-Rel induces reactive oxygen species. The above results suggest that transformation of lymphoid cells by v-Rel may lead to the induction of proapoptotic factors which may be partially negated by the simultaneous induction of telomerase activity. Reactive oxygen species (ROS) are one candidate with these characteristics. Increased production of ROS is used during defense reactions, in which members of the Rel/NF-B family play a critical role (17) . ROS also induce telomere damage followed by apoptosis, while telomerase has the ability to protect against hydroxyl radical-induced apoptosis (68, 82) . To establish if v-Rel-transformed lymphoid cells have high levels of ROS, the levels of reactive oxygen molecules in five v-Rel-transformed cell lines and in three other avian lymphoid cell lines (MSB1, DT95, and DT40) were determined by flow cytometry of dichlorodihydrofluorescein diacetate (H 2 DCFDA)-exposed cells (Fig. 5A) . The level of ROS was high in all v-Rel-transformed cell lines examined relative to that in MSB1 T cells, and four out of five cell lines had higher ROS levels than DT95 and DT40 B cells. The levels of ROS in v-Rel cell lines correlated with their sensitivity to apoptosis induced by the telomerase inhibitor. The 160/8 cell line, which is the most sensitive to exposure to the telomerase inhibitor, had the highest levels of ROS (Table 4 ; Fig. 5A ). To evaluate whether v-Rel expression leads to higher production of ROS in cells, ROS levels were determined in CEFs and in HD11 cells after their transformation by v-Rel (Fig. 5B) . The levels of ROS were more than twofold higher in v-Rel-transformed CEFs than in untransformed cells and four times higher in HD11 cells expressing v-Rel than in control cells, indicating that v-Rel expression increases ROS levels in different cell types.
To assess the mechanism by which v-Rel induces ROS, the levels of mRNA of several genes involved in the production of ROS were determined in HD11 macrophage cells expressing v-Rel (Fig. 5C) . NADPH oxidase represents the major system responsible for increased production of ROS in phagocytes during a defense response against invading microorganisms (16) . The steady-state mRNA levels of several subunits of the NADPH complex specific to hematopoietic cells (p40 phox , p47 phox , and Rac1) increased as a result of v-Rel expression. Another type of reactive molecules produced in immune cells and detected by H 2 DCFDA staining is peroxynitrite anions, which are formed by the reaction of ROS with nitric oxide (R. P. Haugland, Handbook of fluorescent probes and research products, 9th edition; Molecular Probes, Inc., Eugene, OR). The nitric oxide present in immune cells is a product of iNOS (15) . Northern analysis showed that in v-Rel-expressing cells, the level of iNOS mRNA was strongly upregulated. Finally, we analyzed the expression of genes whose products are responsible for ROS degradation. The majority of ROS are degraded by MnSOD and catalase. MnSOD converts the superoxide anion to H 2 O 2 , a reactive intermediate product, which is further processed by catalase (8) . c-Rel is known to increase MnSOD expression without increasing of the levels of catalase, leading to the accumulation of H 2 O 2 and subsequent proliferation arrest or apoptosis of c-Rel-overexpressing cells (8, 9) . Similarly, in our experiment v-Rel induced the expression of MnSOD, eliminating the negative effect of helper virus and increasing the MnSOD level above that detected in uninfected cells. v-Rel did not, however, alter the level of expression of catalase, possibly allowing for H 2 O 2 accumulation because the ROS increased by the NADPH system would not be properly degraded. Collectively, these results demonstrate that v-Rel upregulates the mRNA of several members of the oxygen and nitrogen species regulating systems, which could lead to an increase in their levels in cells.
The expression of TERT increases resistance of chicken cells to challenge by ROS. TERT expression has been shown to protect several cell types against apoptosis induced by oxidative challenge (70) . Therefore, it is plausible that v-Rel-induced telomerase activity contributes to protection of transformed cells against apoptosis resulting from increased levels of ROS in v-Rel-expressing cells. However, the ability of chicken TERT to protect against ROS has not been established. Therefore, we cloned the avian TERT gene, overexpressed it from a retrovirus vector in HD11 cells, and challenged these cells with t-butyl hydroperoxide (t-BHP), which produces oxidative radicals (Fig. 6 ). HD11 cells infected with the retrovirus expressing TERT had high telomerase activity. The extent of apoptosis in these cells was increased only twofold after treatment by t-BHP, while t-BHP treatment of HD11 cells infected with the helper virus resulted in a fivefold increase in apoptosis. These results demonstrate that like human TERT, chicken TERT is able to protect cells against apoptosis induced by oxidative radicals. v-Rel induces the expression of TERT mRNA and TR. The elevated activity of telomerase observed in v-Rel-transformed cells is consistent with the increased expression of TERT and TR subunits of the telomerase complex. The TERT subunit is the main target of the pathways which regulate telomerase activity (20) . The increase in TERT expression is a direct result of the activity of v-Rel, since v-Rel is able to upregulate TERT expression independently of protein synthesis. v-Rel binds to the two B sites located in the TERT promoter and may also increase the expression of TERT by using binding sites of other transcription factors. v-Rel and other Rel/NF-B proteins interact with the Sp1 transcription factor, and v-Rel is capable of increasing transcription activity from Sp1 binding sites (63, 73) . Several Sp1 sites are located close to the transcription start site in the promoter region of the chicken TERT gene.
The expression of TR RNA was substantially increased in v-Rel-transformed lymphocytes. Levels of TR are also often elevated in human tumors (65, 93) . The increased steady-state levels of TR transcripts detected in v-Rel-transformed cells may be due to both increased expression and the stabilization of TR RNA by the increased levels of TERT.
v-Rel regulates the TERT gene by alternative splicing. The chicken TERT gene is extensively regulated by alternative splicing. In normal splenic cells, alternative spliced forms of TERT which encode nonfunctional molecules are by far the most abundant transcripts detected. In contrast, in v-Rel tumor cells, which contain elevated levels of telomerase activity, a large proportion of the TERT transcripts would encode func- tional TERT. Likewise, in most human cells that have low telomerase activity, alternatively spliced TERT transcripts are the most abundant; and in human tumors with high telomerase activity, WT TERT mRNA becomes the dominant transcript (46, 80, 92) . The pathways which regulate the alternative splicing of TERT have not been identified.
Sixteen distinct alternatively spliced chicken TERT transcripts have been detected. The alternatively spliced variants of chicken TERT are all distinct from the seven described human forms. While both genes contain 16 exons, the chicken splice variants involve exons 2 to 11 while the human splice variants described involve exons 5 to 14 (33, 40) . All of the alternatively spliced human forms are suggested to be inactive or to function as dominant-negative forms (19, 90) . Interestingly, the alternatively spliced forms of TERT, containing new stop codons which would encode prematurely terminated proteins, are replaced by alternatively spliced forms with in-frame-spliced TERT transcripts during transformation or activation of chicken lymphocytes. The prematurely terminated mRNA may be recognized by the nonsense-mediated decay mechanism during initial translation and be rapidly degraded (32) . In contrast, in-frame-spliced TERT transcripts could be translated. A recent report indicates that TERT protects cells against apoptosis in a p53-dependent manner and does not require its catalytic domain (66) . Therefore, it is possible that some of the chicken alternative spliced in-frame forms may protect against apoptosis in a similar manner or may acquire full telomerase function by assembling complementing dimers.
Role of telomerase activity in v-Rel transformation. Telomerase activity contributes to transformation in two ways (13, 14, 54) . First, by adding telomeric repeats to the ends of chromosomes, telomerase prevents cells from undergoing apoptosis or senescence triggered by the shortening of the telomeres. Secondly, telomerase also inhibits apoptosis triggered by DNA-damaging agents by a still largely unknown mechanism. v-Rel-induced telomerase activity apparently is important for cell transformation in both ways. Telomeres in v-Rel cell lines are longer than those in nontransformed chicken lymphocytes, suggesting that v-Rel transformation of hematopoietic cells is not accompanied by a mortality crisis induced by short telomeres. However, despite their "well-maintained" telomeres, v-Rel cell lines require the constitutive antiapoptotic function of telomerase for their survival. The apoptotic death of v-Reltransformed lymphoid cells within 24 h after telomerase inhibition is unlikely to be the result of the shortening of telomeric sequences below a critical level due to the end replication problem. The increased levels of ROS induced by v-Rel coincide with the increased sensitivity of these cells to inhibition of telomerase, and the ectopic expression of TERT protects cells against oxidative challenge. Taken together, these results are consistent with a model which suggests that telomerase activity is necessary to increase the threshold for an apoptotic response induced by ROS. Higher telomerase activity would increase the maintenance of telomeres otherwise damaged by free radicals, which often result in apoptosis or senescence (31, 83) . Telomeric DNA is known to be more sensitive to damage by oxidative stress than nontelomeric DNA; therefore, telomeric DNA may function as a sensor of DNA damage (83) . Differential levels of telomerase may establish the sensitivity of this sensor. Reducing the sensitivity of cells to ROS by increasing telomerase activity would therefore protect v-Rel-transformed cells from apoptosis induced by high levels of ROS.
Parallel between v-Rel transformation and chronic inflammation. The expression of most oncogenes does not result in the activation of telomerase (84) . The rapid induction of telomerase during v-Rel-mediated transformation is consistent with the unprecedented ability of v-Rel to efficiently transform and immortalize lymphoid cells in vitro. The Rel/NF-B family plays a major role in the activation of genes leading to an inflammatory response (81) . The events which occur in cells during transformation by v-Rel resemble many of the events which occur during an inflammatory response. v-Rel induces the expression of inflammatory cytokines, such as interleukin 1 (IL-1), IL-6, IL-8 (CEF-4), and MIP1␤ and increases the levels of ROS (64a; also data not shown). The parallels with human carcinogenesis are significant. The activation of human telomerase by Rel/NF-B is attributed to IL-6 and TNF-␣ signaling (2, 3). These pathways are accompanied by increased levels of ROS and consequently an increased probability that the cells will undergo apoptosis. The activation of telomerase by Rel/NF-B may partially protect these cells from the negative effects of ROS by delaying the induction of apoptosis to allow for DNA repair as well as contributing to telomere maintenance. However, the long-term activation of genes involved in the inflammatory response may eventually result in DNA mutations which ultimately lead to cancer development (89) . Chronic inflammation is frequently associated with the development of many cancer types, including pancreatic, liver, stomach, and lung (1) . The fact that v-Rel, the oncogenic member of the Rel/NF-B family, simultaneously activates ROS and telomerase provides an additional rationale for the recent focus of anticancer therapies based on the inhibition of Rel/ NF-B (11, 39, 50) .
